FOXA1 and prostate carcinoma: Altogether, our findings uncover a regulatory axis whereby HIF1α negatively regulates FOXA1 protein stability in prostate cancer cells, thereby suppressing androgen receptor signaling and promoting hypoxia-responsive transcriptional programs.